Satyadeeptha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.88 Cr
- Company Age 37 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 109.43 Cr
- Satisfied Charges ₹ 48.68 Cr
- Revenue Growth 100.82%
- Profit Growth 309.91%
- Ebitda 6.94%
- Net Worth 0.75%
- Total Assets 17.28%
About Satyadeeptha Pharmaceuticals
Satyadeeptha Pharmaceuticals Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 March 1987 and has a history of 37 years and ten months. Its registered office is in Bidar, Karnataka, India.
The Corporate was formerly known as Gladwin Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.88 Cr.
The company currently has active open charges totaling ₹109.43 Cr. The company has closed loans amounting to ₹48.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Bidar, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110KA1993PLC013900
-
Company No.
013900
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
10 Mar 1987
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Satyadeeptha Pharmaceuticals Limited offer?
Satyadeeptha Pharmaceuticals Limited offers a wide range of products and services, including Pharmaceutical Medicine, Anti Infective Drugs & Medicines, HIV Drugs, Antidepressant & Anti Anxiety Medicines, Antidepressant Tablet, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at Satyadeeptha Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surapaneni Ramakrishna
|
Managing Director | 18-Jan-1993 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srinivasarao Bolla
|
Director | 02-Mar-2016 | Current |
|
Surapaneni Rao
|
Whole-Time Director | 24-Feb-2023 | Current |
|
Nageswara Balusupati
|
Director | 17-Oct-2022 | Current |
|
Prasada Kalluri
|
Director | 25-Sep-2021 | Current |
|
Surapaneni Sarojinidevi
|
Whole-Time Director | 20-Mar-1999 | Current |
Financial Performance of Satyadeeptha Pharmaceuticals.
Satyadeeptha Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 100.82% increase. The company also saw a substantial improvement in profitability, with a 309.91% increase in profit. The company's net worth moved up by a moderate rise of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyadeeptha Pharmaceuticals?
In 2023, Satyadeeptha Pharmaceuticals had a promoter holding of 95.93% and a public holding of 4.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sophia Traexpo LimitedSrinivasarao Bolla is a mutual person
-
Hemair Systems India LimitedNageswara Balusupati is a mutual person
-
Alpha Marine LimitedPrasada Kalluri is a mutual person
-
Silly Monks Entertainment LimitedPrasada Kalluri is a mutual person
-
Gayatri Hi-Tech Hotels LimitedPrasada Kalluri is a mutual person
-
Genesis Ibrc India LimitedPrasada Kalluri is a mutual person
Charges (Loans)
₹109.43 Cr
₹48.68 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 65.58 Cr
- Canara Bank : 43.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2022 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 07 Oct 2022 | Hdfc Bank Limited | ₹4.52 Cr | Open |
| 07 Oct 2022 | Hdfc Bank Limited | ₹2.26 Cr | Open |
| 05 Jan 2022 | Canara Bank | ₹3.20 Cr | Open |
| 06 Sep 2021 | Hdfc Bank Limited | ₹25.30 Cr | Open |
How Many Employees Work at Satyadeeptha Pharmaceuticals?
Satyadeeptha Pharmaceuticals has a workforce of 166 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyadeeptha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyadeeptha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
